J. Sire

发表

Induction of NF-KB during monocyte differentiation by HIV type 1 infection.

B. Spire, P. Le Bouteiller, I. Hirsch, 1991, Journal of immunology.

Recognition of oligonucleotide-encoded T cell epitopes introduced into a gene unrelated to the original antigen

G. Chimini, B. Jordan, J. Sire, 1989, The Journal of experimental medicine.

Reversion of the Lethal Phenotype of an HIV-1 Integrase Mutant Virus by Overexpression of the Same Integrase Mutant Protein*

G. Quérat, S. Priet, J. Sire, 2003, Journal of Biological Chemistry.

The HIV‐1 Vpr co‐activator induces a conformational change in TFIIB

F. Rey, R. Pomerantz, B. Spire, 1999, FEBS letters.

Diversity of HIV-1 Vpr Interactions Involves Usage of the WXXF Motif of Host Cell Proteins*

R. Pomerantz, L. Duan, J. Sire, 1998, The Journal of Biological Chemistry.

Nonstructural NS1 proteins of several mosquito-borne Flavivirus do not inhibit TLR3 signaling.

X. de Lamballerie, G. Quérat, C. Baronti, 2010, Virology.

Secretion of extracellular factor(s) induced by X-irradiation activates the HIV type 1 long terminal repeat through its kappaB motif.

F. Rey, P. Lécine, B. Kahn-Perlès, 1998, AIDS research and human retroviruses.

HIV1 infection of human monocytes and macrophages promotes induction or translocation of NF-KB-related factors.

G. Quérat, C. Neuveut, M. Suzan, 1991, Research in virology.

HLA Class I Genes: From Structure to Expression, Serology and Function

T. Strachan, F. Lemonnier, R. Sodoyer, 1985, Immunological reviews.

The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.

F. Rey, B. Spire, I. Agostini, 1996, Journal of molecular biology.

Transfection of murine LMTK− cells with purified HLA class I genes

F. Lemonnier, R. Sodoyer, B. Kahn-Perlès, 1986, Immunogenetics.

Involvement of Viral Regulatory Gene Products in the Pathogenesis of Lentivirus Infections a

G. Arbuthnott, J. Clements, R. Vigne, 1994, Annals of the New York Academy of Sciences.

Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells

F. Rey, B. Spire, F. Clavel, 1997, Journal of virology.

Human Immunodeficiency Virus Type 1 Vif Protein Binds to the Pr 55 Gag Precursor

B. Spire, P. Boulanger, R. Vigne, 1997 .

Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps

F. Rey, B. Spire, R. Vigne, 1995, Journal of virology.

Mapping of A3 and A2 polymorphic determinants on hybrid HLA antigens

F. Lemonnier, R. Sodoyer, A. Toubert, 2004, Immunogenetics.

A fission yeast homologue of the human uracil-DNA-glycosylase and their roles in causing DNA damage after overexpression.

R. Elder, Yuqi Zhao, S. Priet, 2003, Biochemical and biophysical research communications.

The env gene variability is not directly related to the high cytopathogenicity of an HIV1 variant.

J. Chermann, B. Spire, I. Hirsch, 1990, Virology.

Epitope mapping of HLA-B27 and HLA-B7 antigens by using intradomain recombinants.

B. Amor, F. Lemonnier, R. Sodoyer, 1988, Journal of immunology.

Recognition of hybrid HLA molecules expressed on murine P815 cells using human alloreactive cytotoxic T lymphocytes.

B. Kahn-Perlès, J. Levy, B. Jordan, 1987, Annales de l'Institut Pasteur. Immunology.

Hybrid genes between HLA-A2 and HLA-A3 constructed by in vivo recombination allow mapping of HLA-A2 and HLA-A3 polymorphic antigenic determinants.

F. Lemonnier, R. Sodoyer, A. Toubert, 1988, Journal of immunology.

Serological and structural analysis of HLA class I molecules: beta 2-microglobulin interacts with the two external domains of the HLA class I heavy chain.

A. Toubert, P. Pontarotti, B. Kahn-Perlès, 1987, Annales de l'Institut Pasteur. Immunology.

Rat IgD myeloma protein: cell‐free translation of the δ mRNA and biochemical analysis of intracellular and membrane δ chain

G. Alcaraz, B. Jordan, J. Sire, 1981, European journal of immunology.

Glutamic residue 438 within the protease-sensitive subdomain of HIV-1 reverse transcriptase is critical for heterodimer processing in viral particles.

B. Canard, L. Damier, G. Quérat, 2001, Virology.

An integrated system to study multiply substituted human immunodeficiency virus type 1 reverse transcriptase.

S. Longhi, B. Canard, J. Sire, 2001, Analytical biochemistry.

The Valine-to-Threonine 75 Substitution in Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Its Relation with Stavudine Resistance*

S. Longhi, B. Canard, C. Guerreiro, 2001, The Journal of Biological Chemistry.

A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells.

F. Rey, José, B. Spire, 1998, The Journal of general virology.

Synthesis, in vitro antiviral evaluation, and stability studies of novel alpha-borano-nucleotide analogues of 9-[2-(phosphonomethoxy)ethyl]adenine and (R)-9-[2-(phosphonomethoxy)propyl]adenine.

J. Neyts, J. Balzarini, B. Canard, 2006, Journal of medicinal chemistry.

Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor

B. Spire, P. Boulanger, R. Vigne, 1997, Journal of virology.

Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus.

F. Galibert, J. Chermann, F. Barré-Sinoussi, 1989, Gene.

The visna transcriptional activator Tat: effects on the viral LTR and on cellular genes.

J. Clements, R. Vigne, C. Neuveut, 1993, Virology.

A Loss of Viral Replicative Capacity Correlates with Altered DNA Polymerization Kinetics by the Human Immunodeficiency Virus Reverse Transcriptase Bearing the K65R and L74V Dideoxynucleoside Resistance Substitutions*

J. Courcambeck, B. Canard, J. Deval, 2004, Journal of Biological Chemistry.

Synthesis and antiviral activity of boranophosphonate isosteres of AZT and d4T monophosphates.

C. De Michelis, J. Neyts, J. Balzarini, 2010, European journal of medicinal chemistry.

Uracils as a cellular weapon against viruses and mechanisms of viral escape.

G. Quérat, S. Priet, J. Sire, 2006, Current HIV research.

Uracil within DNA: an actor of antiviral immunity

G. Quérat, S. Priet, J. Sire, 2008, Retrovirology.

Tryptic and plasmic cleavage of a rat myeloma IgD.

G. Alcaraz, H. Bazin, B. Kahn-Perlès, 1981, Molecular immunology.

Rat immunoglobulin delta heavy chain gene: nucleotide sequence derived from cloned cDNA.

C. Auffray, B. Jordan, J. Sire, 1982, Gene.

NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions.

B. Roques, H. Rocquigny, H. de Rocquigny, 1999, Journal of molecular biology.

Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme

F. Rey, S. Benichou, R. Benarous, 1996, Journal of virology.

Biochemical characterization of an Fc receptor of rabbit lymphocytes

B. Kahn-Perlès, J. Sire, A. Bourgois, 1980, European journal of immunology.

Identification of an IgD‐like surface immunoglobulin on rabbit lymphocytes

J. Sire, A. Bourgois, A. Collé, 1979, European journal of immunology.

Synthetic Vpr Protein Activates Activator Protein-1, c-Jun N-terminal Kinase, and NF-κB and Stimulates HIV-1 Transcription in Promonocytic Cells and Primary Macrophages*

C. Van Lint, B. Aggarwal, B. Roques, 2005, Journal of Biological Chemistry.

Rat IgD myeloma protein: cell-free translation of the delta mRNA and biochemical analysis of intracellular and membrane delta chain.

G. Alcaraz, B. Jordan, J. Sire, 1981, European journal of immunology.

The Human Polycomb Group EED Protein Interacts with the Integrase of Human Immunodeficiency Virus Type 1

J. Mouscadet, O. Schwartz, B. Gay, 2003, Journal of Virology.

DNA Repair Enzyme Uracil DNA Glycosylase Is Specifically Incorporated into Human Immunodeficiency Virus Type 1 Viral Particles through a Vpr-Independent Mechanism

F. Rey, I. Agostini, R. Vigne, 1999, Journal of Virology.

Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest

M. A. Vodicka, M. Emerman, L. Selig, 1997, Journal of virology.

HIV-1 Replication through hHR23A-Mediated Interaction of Vpr with 26S Proteasome

M. Bukrinsky, Ge Li, R. Elder, 2010, PloS one.

HIV-1-associated uracil DNA glycosylase activity controls dUTP misincorporation in viral DNA and is essential to the HIV-1 life cycle.

B. Canard, G. Quérat, S. Priet, 2005, Molecular cell.

Differential incorporation of uracil DNA glycosylase UNG2 into HIV-1, HIV-2, and SIV(MAC) viral particles.

G. Quérat, S. Priet, J. Sire, 2003, Virology.

Functional Role of HIV-1 Virion-associated Uracil DNA Glycosylase 2 in the Correction of G:U Mispairs to G:C Pairs*

G. Quérat, S. Priet, J. Sire, 2003, The Journal of Biological Chemistry.

Differences in replication and cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) are not determined by long terminal repeats (LTR).

J. Chermann, B. Spire, I. Hirsch, 1990, Virology.